Anavex Life Sciences Corporation (AVXL)
NASDAQ
Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -72.1 | -66.852 | -105.804 | -87.789 | -38.65 | -30.527 | -30.939 | -29.661 |
Return on Equity (%) | -88.083 | -78.011 | -128.957 | -110.59 | -42.58 | -32.714 | -33.414 | -32.812 |
Return on Invested Capital (%) | -103.357 | -86.942 | -143.332 | -130.92 | -47.416 | -35.006 | -39.222 | -40.346 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.56 | 0.446 | 0.385 | 0.439 | 1.987 | 1.828 | 1.731 | 1.418 |
Earnings Per Share | -0.311 | -0.38 | -0.499 | -0.424 | -0.499 | -0.616 | -0.58 | -0.507 |
Cash Per Share | 0.633 | 0.499 | 0.421 | 0.471 | 2.004 | 1.914 | 1.843 | 1.559 |
Working Capital Per Share | 0.559 | 0.445 | 0.385 | 0.439 | 1.987 | 1.828 | 1.731 | 1.418 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.001 | N/A | N/A | N/A |
EBIT Per Share | -0.309 | -0.378 | -0.498 | -0.423 | -0.496 | -0.611 | -0.58 | -0.507 |
EBITDA Per Share | -0.309 | -0.378 | -0.498 | -0.423 | -0.496 | -0.611 | -0.58 | -0.507 |
Free Cash Flow Per Share | -0.311 | -0.38 | -0.499 | -0.424 | -0.499 | -0.616 | -0.58 | -0.507 |
Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 43.33M | 45.93M | 52.65M | 62.05M | 75.92M | 77.94M | N/A | N/A |
Year End September 29 2024 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 78.03M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 1.03B |
Price to Earnings Ratio | -23.89 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.77 |
Price to Book Ratio | 8.54 |
Dividend Yield | - |
Shares Outstanding | 84.82M |
Average Volume (1 week) | 4.86M |
Average Volume (1 Month) | 2.09M |
52 Week Change | 92.71% |
52 Week High | 14.4405 |
52 Week Low | 3.25 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.